FBI, State Investigate Drug Firm |
|
|
|
The Chicago Tribune's lead article today (Wednesday January 31, 2007) has the headline "FBI, state investigate drug firm." The article concerns billing fraud by a DCFS-contract agency K.K. Bio-Science Inc. It reports that the current FBI probe follows a DCFS Office of Inspector General report. It does not state when, in the 15 year history of the contract with this company, questions about their fraudulent billing practices first arose or how those concerns came to the OIG's attention.
An issue that is not discussed in the news article but which is of great
concern to the Family Defense Center is whether families are the victims of
false court reports related to the falsified billings for drug tests that were
not done. If so, in some cases children may have been returned to
parents who were thought to be drug free but were not and in other cases, false
positives may not have been retested to show that they were false, in which case
a child might have been kept in care on the basis for a false positive that
should have been retested. While we have no information at this time as to
the full scope of the reported fraud, the central role of drug testing in
determining whether children are returned home or remain in foster care makes it
vitally important that a full investigation and review of the court reports
relied upon by DCFS and its agents and presented in the juvenile court
occurred. The Family Defense Center is willing and able to speak confidentially to any family member who believes they have were the victim of a fraudulent report by K.K. Bio Science Inc. as that report relates to a DCFS or juvenile court matter. (If the drug test report was used was in domestic relations court or criminal court, our limited resources would not extend to investigating the merits as to those reports and their impact).
|
| < Prev | Next > |
|---|

